رجوع
مُدرج أيضًا باسم
SAUHF
OTC
نطاق اليوم
KWD 9.60
KWD 9.82
نطاق 52 أسبوعًا
KWD 9.44
KWD 14.18
حجم التداول
21,350
متوسط 50 يوم / 200 يوم
KWD 11.79
/
KWD 12.00
الإغلاق السابق
KWD 9.45
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 45.1 | 0.4 |
| P/B | 7.1 | 2.9 |
| ROE % | 16.3 | 3.7 |
| Net Margin % | 13.7 | 3.9 |
| Rev Growth 5Y % | 5.3 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.543
KWD 0.533 – KWD 0.562
|
4.1 B | 1 |
| FY2029 |
KWD 0.465
KWD 0.456 – KWD 0.481
|
3.7 B | 1 |
| FY2028 |
KWD 0.424
KWD 0.416 – KWD 0.439
|
3.3 B | 1 |
النقاط الرئيسية
Revenue grew 5.32% annually over 5 years — modest growth
Earnings declined -11.95% over the past year
ROE of 16.27% — decent returns on equity
Debt/Equity of 0.30 — conservative balance sheet
Generating 314.96M in free cash flow
P/E of 45.05 — premium valuation
النمو
Revenue Growth (5Y)
5.32%
Revenue (1Y)-0.64%
Earnings (1Y)-11.95%
FCF Growth (3Y)-5.44%
الجودة
Return on Equity
16.27%
ROIC13.97%
Net Margin13.74%
Op. Margin21.07%
الأمان
Debt / Equity
0.30
Current Ratio2.21
Interest Coverage0.00
التقييم
P/E Ratio
45.05
P/B Ratio7.12
EV/EBITDA29.71
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.64% | Revenue Growth (3Y) | 1.56% |
| Earnings Growth (1Y) | -11.95% | Earnings Growth (3Y) | 17.88% |
| Revenue Growth (5Y) | 5.32% | Earnings Growth (5Y) | -3.61% |
| Profitability | |||
| Revenue (TTM) | 2.49B | Net Income (TTM) | 341.91M |
| ROE | 16.27% | ROA | 8.95% |
| Gross Margin | 68.60% | Operating Margin | 21.07% |
| Net Margin | 13.74% | Free Cash Flow (TTM) | 314.96M |
| ROIC | 13.97% | FCF Growth (3Y) | -5.44% |
| Safety | |||
| Debt / Equity | 0.30 | Current Ratio | 2.21 |
| Interest Coverage | 0.00 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 45.05 | P/B Ratio | 7.12 |
| P/S Ratio | 6.19 | PEG Ratio | -3.99 |
| EV/EBITDA | 29.71 | Dividend Yield | 0.01% |
| Market Cap | 15.40B | Enterprise Value | 15.58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.49B | 2.50B | 2.41B | 2.32B | 2.02B |
| Net Income | 341.91M | 388.32M | 246.07M | 434.79M | 396.08M |
| EPS (Diluted) | 0.21 | 0.24 | 0.15 | 0.27 | 0.25 |
| Gross Profit | 1.71B | 1.78B | 1.79B | 1.70B | 1.53B |
| Operating Income | 524.32M | 601.00M | 410.97M | 535.35M | 542.58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.82B | 3.62B | 3.40B | 3.45B | 3.05B |
| Total Liabilities | 1.65B | 1.58B | 1.56B | 1.60B | 1.55B |
| Shareholders' Equity | 2.16B | 2.04B | 1.84B | 1.85B | 1.50B |
| Total Debt | 651.46M | 413.89M | 412.35M | 781.61M | 706.57M |
| Cash & Equivalents | 475.97M | 375.49M | 410.31M | 696.10M | 880.42M |
| Current Assets | 1.65B | 1.52B | 1.39B | 1.59B | 1.53B |
| Current Liabilities | 744.45M | 943.16M | 714.18M | 972.10M | 562.63M |